132 related articles for article (PubMed ID: 8187778)
1. Acute leukaemias in adult Ethiopians in a teaching hospital.
Shamebo M
Ethiop Med J; 1994 Jan; 32(1):17-25. PubMed ID: 8187778
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma in Ethiopians: analysis of 22 cases.
Shamebo M; Tekle-Haimanot R
Ethiop Med J; 1992 Jul; 30(3):143-9. PubMed ID: 1396616
[TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic leukaemia in Ethiopians.
Shamebo M; Gebremedhin A
East Afr Med J; 1996 Oct; 73(10):643-6. PubMed ID: 8997843
[TBL] [Abstract][Full Text] [Related]
4. Leukaemia in adult Ethiopians.
Shamebo M
Ethiop Med J; 1990 Jan; 28(1):31-7. PubMed ID: 2307156
[TBL] [Abstract][Full Text] [Related]
5. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
6. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
[TBL] [Abstract][Full Text] [Related]
7. Chronic idiopathic thrombocytopenic purpura (ITP) in adult Ethiopians: clinical findings and response to therapy.
Shamebo M; Johnson O
Ethiop Med J; 1991 Apr; 29(2):71-80. PubMed ID: 2060509
[TBL] [Abstract][Full Text] [Related]
8. Acute lymphoblastic leukemia in the elderly: The Edouard Herriot Hospital experience.
Thomas X; Olteanu N; Charrin C; Lhéritier V; Magaud JP; Fiere D
Am J Hematol; 2001 Jun; 67(2):73-83. PubMed ID: 11343378
[TBL] [Abstract][Full Text] [Related]
9. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
Yavuz S; Paydas S; Disel U; Sahin B
Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532
[TBL] [Abstract][Full Text] [Related]
10. Acute lymphoblastic leukemia in young adults: two chemotherapeutic protocols for the treatment of 46 patients.
Ho CL; Chen YC; Kao WY; Chao TY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):45-52. PubMed ID: 10645050
[TBL] [Abstract][Full Text] [Related]
11. The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
Sanders KE; Ha CS; Cortes-Franco JE; Koller CA; Kantarjian HM; Cox JD
Cancer; 2004 May; 100(10):2176-80. PubMed ID: 15139061
[TBL] [Abstract][Full Text] [Related]
12. Prolonged haematological toxicity from the hyper-CVAD regimen: manifestations, frequency, and natural history in a cohort of 125 consecutive patients.
Gill S; Lane SW; Crawford J; Cull G; Joske D; Marlton P; Mollee PN; Prince HM; Seymour JF
Ann Hematol; 2008 Sep; 87(9):727-34. PubMed ID: 18401583
[TBL] [Abstract][Full Text] [Related]
13. [Acute leukemia in the elderly patient. Forty case reports].
Laatiri MA; Chehata S; Ajmi F; Amouri A; Bouaouina N; Saad A; Ennabli S
Tunis Med; 2000; 78(8-9):503-7. PubMed ID: 11190727
[TBL] [Abstract][Full Text] [Related]
14. [Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].
Rodríguez JN; Fernández-Jurado A; Martino ML; Diéguez JC; Moreno MV; Quesada JA; Polo B; Cañavate M; Amian A; Prados D
Sangre (Barc); 1998 Feb; 43(1):35-9. PubMed ID: 9580427
[TBL] [Abstract][Full Text] [Related]
15. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
[TBL] [Abstract][Full Text] [Related]
16. Acute Lympoblastic Leukaemia in seventy Iraqi adults: clinical and haematological findings and outcome of therapy.
Yahya HI; Al-Allawi NA; Mattar Y
Indian J Cancer; 2000; 37(2-3):85-90. PubMed ID: 11876615
[TBL] [Abstract][Full Text] [Related]
17. Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.
Clavio M; Venturino C; Pierri I; Garrone A; Miglino M; Canepa L; Balleari E; Balocco M; Michelis GL; Ballerini F; Gobbi M
Ann Hematol; 2004 Nov; 83(11):696-703. PubMed ID: 15322763
[TBL] [Abstract][Full Text] [Related]
18. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
Ribera JM; Ortega JJ; Oriol A; Fontanillas M; Hernández-Rivas JM; Brunet S; García-Conde J; Maldonado J; Zuazu J; Gardella S; Besalduch J; León P; Macià J; Domingo-Albós A; Feliu E; San Miguel JF
Haematologica; 1998 Mar; 83(3):222-30. PubMed ID: 9573676
[TBL] [Abstract][Full Text] [Related]
19. [Cytological features of acute leukaemia in the central region of Tunisia].
Jmili NB; Ben Abdelaziz A; Nagara M; Mahjoub T; Ghannem H; Kortas M
East Mediterr Health J; 2004; 10(4-5):640-7. PubMed ID: 16335657
[TBL] [Abstract][Full Text] [Related]
20. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]